title: Ustekinumab for the treatment of HIV psoriasis.
authors.forename: Vasileios
authors.initials: V
authors.lastname: Paparizos
authors.forename: Efstathios
authors.initials: E
authors.lastname: Rallis
authors.forename: Leuow
authors.initials: L
authors.lastname: Kirsten
authors.forename: Kyriakos
authors.initials: K
authors.lastname: Kyriakis
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003879:Dermatologic Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012536:Scalp Dermatoses / Q000150:complications / Q000188:drug therapy; D060726:Torso; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D007155:Immunologic Factors; D000069549:Ustekinumab